RSV Admissions to Intensive Care Among Newborns Appear to Have Halved After Vaccination Programme

Respiratory syncytial virus (RSV) — a common breathing infection that can be dangerous in very young babies — has long been one of the leading causes of infant hospital admission in winter. The BMJ has now reported that newborn admissions to intensive care units (ICUs) in England appear to have dropped by around half since a national RSV vaccination programme was introduced.

The findings point to a measurable early impact from the programme, though the BMJ’s language is careful — the word “seem” reflects that this is observational data rather than a completed clinical trial.

RSV spreads easily and causes cold-like symptoms in most people. But in newborns and very young infants, it can lead to bronchiolitis (inflammation of the small airways in the lungs), which in serious cases requires intensive care support.

The national programme targets protection in infancy. A reduction of this scale in ICU admissions, if it holds as more data comes in, would represent a meaningful shift in how the NHS manages one of its busiest winter pressures.

No further figures, named researchers, or local Kent-specific data were included in the source material at this stage.

If you’re worried about a baby’s breathing — rapid or laboured breaths, a persistent cough, or difficulty feeding — contact your GP or call NHS 111. In an emergency, call 999.

Key information

• NHS 111 is available 24 hours a day for health concerns about infants and young children
• 999 should be called if a baby is struggling to breathe or becomes unresponsive
• The national RSV vaccination programme is administered through NHS maternity and GP services — speak to your midwife or health visitor for eligibility details